Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 814Uterine Cervical Neoplasms 549Endometrial Neoplasms 467Breast Neoplasms 227Fallopian Tube Neoplasms 202Colorectal Neoplasms 182Carcinoma, Non-Small-Cell Lung 163Neoplasms 140Stomach Neoplasms 128Pancreatic Neoplasms 120Prostatic Neoplasms 109Melanoma 108Neoplasm Metastasis 107Lung Neoplasms 105Carcinoma, Ovarian Epithelial 94Triple Negative Breast Neoplasms 92Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Renal Cell 76Urinary Bladder Neoplasms 75Uterine Neoplasms 67Vulvar Neoplasms 66Colonic Neoplasms 60Uterine Cervical Dysplasia 59Peritoneal Neoplasms 59Carcinoma, Hepatocellular 59Sarcoma 53Carcinoma, Transitional Cell 49Papillomavirus Infections 47

Interventions

Iohexol 1Embolization, Therapeutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chylous Ascites × Gynecologic × 1 year × Clear all
NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
42 enrolled
Gynecologic

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡